Comments on: Secura Bio Presented New Data from its Phase 2 PRIMO Trial of Copiktra® (Duvelisib) in Relapsed or Refractory Peripheral T-cell Lymphoma and Announced Plans for its Phase 3 TERZO Trial at the 2024 American Society of Hematology Meeting https://insideout.vn/secura-bio-presented-new-data-from-its-phase-2-primo-trial-of-copiktra-duvelisib-in-relapsed-or-refractory-peripheral-t-cell-lymphoma-and-announced-plans-for-its-phase-3-terzo-trial-at-the-20/ Inside Out Mon, 09 Dec 2024 12:23:14 +0000 hourly 1 https://wordpress.org/?v=6.7.1